The distress radar is the anomaly-clearance feed. PharmaDB computes the global molecule median, compares each lane against it, and surfaces lanes clearing below 30% as the distress feed. Refresh cadence is weekly.
Surface lanes clearing at a small fraction of global median price. The feed of distress shipments that signal over-inventory, contract lock-ins, or predatory entry.
Sacubitril India → Somalia clears at $1.33/kg median across 13 shipments, just 0.8% of the global sacubitril median of $169.92/kg. The Seychelles lane is the second-deepest distress channel: $3.34/kg on 23 shipments, 2.0% of global. Both lanes are sub-$50k in cleared trade value and may reflect either a single distressed exporter clearing inventory or a tender-driven anomaly. Across the warehouse, eleven lanes cleared below 30% of global median in 2024 for our pricing pool; each is a candidate for action. On our own lanes, contract review or renegotiation. On competitor lanes, an entry or price-recovery opportunity.
Single molecule or full active-lane sweep. Default threshold is lane median below 30% of global molecule median; configurable.
Each affected lane with its median, the global anchor, the percentage gap, and the shipment count. Reverse-chronological.
Citation-anchored brief: the lane list, the discount magnitude, a chip on whether the distress is our side (contract review) or competitor side (entry opportunity), and the recommended action per lane.
Lanes clearing at less than 30% of the molecule's global median are flagged automatically. The threshold is empirically the band where structural distress (oversupply, predatory entry, contract lock-in) is most likely.
Our own distress lanes are contract review triggers; competitor distress lanes are entry windows. The brief tags each accordingly so the user knows which side of the table they are on.
Distress lanes must have at least 10 shipments to enter the feed. Single-shipment anomalies are excluded. The signal is structural, not noise.
Trade aggregates refresh weekly. The radar reruns on every refresh; the brief carries the exact computation timestamp.
A real chat thread in PharmaDB. Type a question, the AI agent runs the tools, the answer lands as a saveable note.
pharmagraph_query Ten distress lanes · 2024 · lane median as percentage of global molecule median · ranked by discount depth.
The distress radar is the anomaly-clearance feed. PharmaDB computes the global molecule median, compares each lane against it, and surfaces lanes clearing below 30% as the distress feed. Refresh cadence is weekly.
A clearance well below the molecule's global median, often driven by over-inventory, contract lock-ins at old prices, predatory pricing by a new entrant, or special institutional tenders. The signal is the gap to global median; the interpretation depends on the lane structure.
Lane medians can themselves be distorted by a single distress exporter. The global molecule median (across all destinations) is the more stable anchor. Lanes far below the global signal that the lane is structurally below normal pricing, not just one outlier within a normal band.
Both look similar on the gap metric. Tender lanes typically have many shipments and active multi-exporter participation; pure distress lanes are smaller and concentrated on one or two exporters. The brief surfaces the shipment count and exporter count alongside so the user can read which it is.
Contract review. The lane should not be cleared at distress prices in perpetuity. Either renegotiate the contract, exit the customer, or find a structurally lower-cost manufacturing route. The brief flags the lane and recommends contract calendar review.
Entry or price-recovery opportunity. A competitor clearing at distress prices is signaling exit or inability to support the lane long-term. When they pull, the lane re-prices; positioning to capture the volume at recovery is the play.
Trade aggregates refresh weekly. The radar reruns on every refresh; the catalog row carries the exact timestamp.
Bring the molecule, the lane, or the supplier you're sourcing this week. The AI agent runs it on PharmaDB in 30 minutes. You keep the brief.